Preoperative neutrophil-lymphocyte ratio is an independent prognostic factor for hepatocellular carcinoma after radical resection
-
摘要:
目的评价术前中性粒细胞与淋巴细胞比值(NLR)对经外科根治性切除的肝细胞癌(HCC)患者预后的影响及其预测价值。方法回顾性分析245例2004年1月1日-2009年12月31日在中国人民解放军总医院接受根治性切除术的HCC患者的临床资料。通过Log-rank单因素分析法评估各临床病理特征包括NLR对总生存时间的影响;采用Cox比例风险模型将有意义的变量进一步行多因素分析。结果以NLR值为1.5、2及3作为分界点,将研究对象分为4组,分别为NLR<1.5、1.5≤NLR<2、2≤NLR<3及NLR≥3,各组中位总生存时间分别为39.6、38.3、25.4和19.9个月,差异具有统计学意义(P=0.003)。多因素分析显示术前外周血NLR、AFP、ALT水平、肿瘤结节数量、肿瘤组织最大径以及门静脉癌栓是影响HCC患者预后的独立危险因素(P值均<0.05)。结论术前外周血NLR的水平可以作为外科切除术后HCC患者的新的预后标志物。
Abstract:Objective To evaluate the effect and predictive value of preoperative neutrophil- lymphocyte ratio( NLR) on the prognosis of patients undergoing radical resection for hepatocellular carcinoma( HCC). Methods The clinical data of 245 patients who received radical resection for HCC in our hospital from 2004 to 2009 were retrospectively analyzed. The effects of clinicopathological parameters including NLR on overall survival( OS) time were assessed by univariate analysis using the log- rank test. The significant variables were further analyzed by multivariate analysis using the Cox regression model. Results Using NLR = 1. 5,2,and 3 as cut- off points,the patients were divided into four groups. The median OS time in groups with NLR < 1. 5,1. 5≤NLR < 2,2≤NLR < 3,and NLR≥3 was 39. 6,38. 3,25. 4,and 19. 9 months,respectively( P = 0. 003). Multivariate analysis showed that preoperative NLR,levels of alpha- fetoprotein and alanine aminotransferase in peripheral blood,number of tumor nodules,maximum size of tumor,and portal vein tumor thrombus were independent prognostic factors for HCC( P < 0. 05). Conclusion Preoperative NLR in peripheral blood is a novel prognostic biomarker for HCC after radical resection.
-
Key words:
- carcinoma,hepatocellular /
- neutrophils /
- lymphocytes /
- hepatectomy /
- prognosis
-
[1]ALISON MR,NICHOLSON LJ,LIN WR.Chronic inflammation and hepatocellular carcinoma[J].Recent Results Cancer Res,2011,185:135-148. [2]CHUA W,CHARLES K,BARACOS V,et al.Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer[J].Br J Cancer,2011,104(8):1288-1295. [3]JUNG MR,PARK YK,JEONG O,et al.Elevated preoperative neutrophil to lymphocyte ratio predicts poor survival following resection in late stage gastric cancer[J].J Surg Oncol,2011,104(5):504-510. [4]AZAB B,BHATT V R,PHOOKAN J,et al.Usefulness of the neutrophil-to-lymphocyte ratio in predicting short-and long-term mortality in breast cancer patients[J].Ann Surg Oncol,2012,19(1):217-224. [5]PICHLER M,HUTTERER G,STOECKIGT C,et al.Validation of the pre-treatment neutrophil–lymphocyte ratio as a prognostic factor in a large European cohort of renal cell carcinoma patients[J].Br J Cancer,2013,108(4):901-907. [6]STOTZ M,GERGER A,EISNER F,et al.Increased neutrophillymphocyte ratio is a poor prognostic factor in patients with primary operable and inoperable pancreatic cancer[J].Br J Cancer,2013,109(2):416-421. [7]DING T,XU J,WANG F,et al.High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection[J].Hum Pathol,2009,40(3):381-389. [8]LI YW,QIU SJ,FAN J,et al.Intratumoral neutrophils:a poor prognostic factor for hepatocellular carcinoma following resection[J].J Hepatol,2011,54(3):497-505. [9]MOORE M,CHUA W,CHARLES K,et al.Inflammation and cancer:causes and consequences[J].Clin Pharmacol Ther,2010,87(4):504-508. [10]HASHIMOTO K,IKEDA Y,KORENAGA D,et al.The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma[J].Cancer,2005,103(9):1856-1864. [11]ISHIZUKA M,KUBOTA K,KITA J,et al.Impact of an inflammation-based prognostic system on patients undergoing surgery for hepatocellular carcinoma:a retrospective study of 398 Japanese patients[J].Am J Surg,2012,203(1):101-106. [12]PINATO D,NORTH B,SHARMA R.A novel,externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma:the prognostic nutritional index(PNI)[J].Br J Cancer,2012,106(8):1439-1445. [13]CHEN TM,LIN CC,HUANG PT,et al.Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation[J].J Gastroenterol Hepatol,2012,27(3):553-561. [14]HUANG ZL,LUO J,CHEN MS,et al.Blood neutrophil-to-lymphocyte ratio predicts survival in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization[J].J Vasc Interv Radiol,2011,22(5):702-709. [15]XIAO WK,CHEN D,LI SQ,et al.Prognostic significance of neutrophil-lymphocyte ratio in hepatocellular carcinoma:a meta-analysis[J].BMC Cancer,2014,14(1):117. [16]YUEN MF,HOU JL,CHUTAPUTTI A.Hepatocellular carcinoma in the Asia pacific region[J].J Gastroenterol Hepatol,2009,24(3):346-353. [17]KINOSHITA A,ONODA H,IMAI N,et al.Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma[J].Br J Cancer,2012,107(6):988-993. [18]ZHANG TT,BAI L.Progress on the relationship between hepatocellular carcinoma and chronic inflammation[J].Chinese Clin Oncol,2014,19(8):752-758.(in Chinese)张婷婷,白莉.肝细胞癌和慢性炎症相互关系的研究进展[J].临床肿瘤学杂志,2014,19(8):752-758. [19]MAXWELL PJ,COULTER J,WALKER SM,et al.Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma[J].Eur Urol,2013,64(2):177-188. [20]KUSUMANTO YH,DAM WA,HOSPERS GA,et al.Platelets and granulocytes,in particular the neutrophils,form important compartments for circulating vascular endothelial growth factor[J].Angiogenesis,2003,6(4):283-287. [21]SIVARAMAKRISHNAN V,NIRANJALI DEVARAJ S.Morin regulates the expression of NF-κB-p65,COX-2 and matrix metalloproteinases in diethylnitrosamine induced rat hepatocellular carcinoma[J].Chem Biol Interact,2009,180(3):353-359. [22]DING PR,AN X,ZHANG RX,et al.Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer[J].Int J Colorectal Dis,2010,25(12):1427-1433.
计量
- 文章访问数: 1982
- HTML全文浏览量: 5
- PDF下载量: 721
- 被引次数: 0